Literature DB >> 22136745

Population mobility and the changing epidemics of HIV-2 in Portugal.

A C Carvalho1, E Valadas, L França, C Carvalho, M J Aleixo, J Mendez, R Marques, A Sarmento, M Doroana, F Antunes, T Branco, M Aguas, R Sarmento E Castro, J V Lazarus, H Barros.   

Abstract

INTRODUCTION: Portugal is the European country with the highest frequency of HIV-2 infection, which is mainly concentrated in West Africa. The cumulative number of notified HIV-2 infections in Portugal was 1813 by the end of December 2008. To better characterize the dynamics of HIV-2 infection in the country and to obtain data that may be of use in the prevention of the spread of HIV-2, we evaluated a large pooled sample of patients. PATIENTS AND METHODS: Five Portuguese hospitals provided data on HIV-2-infected patients from 1984 to the end of 2007. Data concerning demographic characteristics and clinical variables were extracted. Patients were stratified according to date of diagnosis in approximately 5-year categories.
RESULTS: The sample included 442 patients, accounting for 37% of all HIV-2 infections notified in Portugal during that period. HIV-2-infected patients showed clearly different characteristics according to the period of diagnosis. Until 2000, the majority of HIV-2-infected patients were Portuguese-born males living in the north of the country. From 2000 to 2007, most of the patients diagnosed with HIV-2 infection had a West African origin, were predominantly female and were living in the capital, Lisbon. The average age at diagnosis and loss to follow-up significantly increased over time.
CONCLUSION: HIV-2 infection has been documented in Portugal since the early 1980s and its epidemiology appears to reflect changes in population movement. These include the movements of soldiers and repatriates from African territories during the independence wars and, later, migration and mobility from high-endemicity areas. The findings of this study stress the importance of promoting migrant-sensitive health care.
© 2011 British HIV Association.

Entities:  

Mesh:

Year:  2011        PMID: 22136745     DOI: 10.1111/j.1468-1293.2011.00963.x

Source DB:  PubMed          Journal:  HIV Med        ISSN: 1464-2662            Impact factor:   3.180


  3 in total

1.  Inhibitory Effects of HIV-2 Vpx on Replication of HIV-1.

Authors:  Mohamed Mahdi; Zsófia Szojka; János András Mótyán; József Tőzsér
Journal:  J Virol       Date:  2018-06-29       Impact factor: 5.103

2.  A modular system to evaluate the efficacy of protease inhibitors against HIV-2.

Authors:  Mohamed Mahdi; Krisztina Matúz; Ferenc Tóth; József Tőzsér
Journal:  PLoS One       Date:  2014-11-24       Impact factor: 3.240

3.  Inhibition Profiling of Retroviral Protease Inhibitors Using an HIV-2 Modular System.

Authors:  Mohamed Mahdi; Zsófia Szojka; János András Mótyán; József Tőzsér
Journal:  Viruses       Date:  2015-11-27       Impact factor: 5.048

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.